Skip to main content
Clinical Trials/NCT00503334
NCT00503334CompletedNot Applicable

Efficacy and Tolerability of a Preoperative Oral Nutritional Supplement (preOP Booster) Versus Placebo in Visceral Surgery

Fresenius Kabi1 site in 1 country36 target enrollmentStarted: July 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
36
Locations
1
Primary Endpoint
laboratory measurements: total endogenous antioxidant capacity, free radicals, CRP;

Study Overview

Brief Summary

The purpose of this pilot study is to investigate the effect of an oral nutritional supplement (preOP booster) versus placebo regarding metabolic criteria in patients undergoing elective pancreaticoduodenectomy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Elective pancreaticoduodenectomy

Exclusion Criteria

  • •Concomitant chemotherapy
  • •Severe malnutrition (SGA score C)
  • •Conditions affecting gastric emptying

Arms & Interventions

preOP booster

Experimental

Intervention: preOP booster (oral nutritional supplement, food for special medical purposes) (Dietary Supplement)

preOP booster placebo

Placebo Comparator

Intervention: preOP booster (oral nutritional supplement, food for special medical purposes) (Dietary Supplement)

Outcomes

Primary Outcomes

laboratory measurements: total endogenous antioxidant capacity, free radicals, CRP;

Time Frame: up to 30 days after surgery

Secondary Outcomes

  • postoperative complications, pre- and postoperative discomfort (well-being), muscle strength at 7 days post-op, length of stay (hospital / ICU), ambulation time, gastro intestinal tolerance(up to 30 days after surgery)

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials